Intervention

Placebo to NVA237

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

4 shown

Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled AsthmaNCT02127697 · 2015-03-01

Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01922271 · 2013-08-01

Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICSNCT01757015 · 2013-04-01

Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01613326 · 2012-06-01

Common conditions

Chronic Obstructive Pulmonary Disease3 Asthma1

Leading sponsors

Novartis Pharmaceuticals4

Trial status mix

COMPLETED2

WITHDRAWN2

Phase mix

PHASE33

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.